Wednesday, March 15, 2017
Patient noncompliance is extremely costly in terms of reduced patient health and lost revenue opportunity. SPI Pharma offers excipient technologies and drug development services supporting the formulation of patient-friendly oral dosage forms ...
Wednesday, March 15, 2017
Oral solid dose (OSD) form medications remain the
industry juggernaut. Though biopharmaceuticals
continue to grow and evolve, offering new and unique
treatment options, small-molecule drugs maintain their
dominance with OSD medications leading ...